MyFinsight
Home
Blog
About
Cash and cash
equivalents
$676,114K
(39.39%↑ Y/Y)
Marketable securities
$222,361K
(11.80%↑ Y/Y)
Prepaid expenses and
other current assets
$39,414K
(181.03%↑ Y/Y)
Property and equipmentat
cost
$34,287K
(156.77%↑ Y/Y)
Total current assets
$937,889K
(34.38%↑ Y/Y)
Property and equipment,
net
$24,559K
(332.76%↑ Y/Y)
Right-of-use assets
$20,256K
(-11.39%↓ Y/Y)
Restricted cash and other
assets
$11,309K
(350.92%↑ Y/Y)
Less accumulated
depreciation and...
$9,728K
(26.70%↑ Y/Y)
Total assets
$994,013K
(36.35%↑ Y/Y)
Total liabilities and
stockholders equity
$994,013K
(36.35%↑ Y/Y)
Total stockholders
equity
$702,151K
(22.87%↑ Y/Y)
Total liabilities
$291,862K
(85.25%↑ Y/Y)
Accumulated deficit
-$1,695,552K
(-44.16%↓ Y/Y)
Accumulated other
comprehensive (loss) gain
-$353K
(-240.08%↓ Y/Y)
Additional paid-in capital
$2,398,040K
(37.24%↑ Y/Y)
Long-term debt, net
$199,328K
(101.72%↑ Y/Y)
Total current
liabilities
$78,029K
(88.15%↑ Y/Y)
Lease liabilities,
net of current...
$14,505K
(-15.97%↓ Y/Y)
Common stock, 0.0001
par value...
$16K
(45.45%↑ Y/Y)
Unamortized debt discount
and issuance costs
$2,009K
(67.98%↑ Y/Y)
Principal term loan
balance
$200,000K
(100.00%↑ Y/Y)
Accrued expenses and
other current...
$46,359K
(106.46%↑ Y/Y)
Vendor financing
arrangement
$14,151K
Accounts payable
$12,153K
(-13.29%↓ Y/Y)
Lease liabilities
$5,366K
(7.28%↑ Y/Y)
Accrued end of term fee
$1,337K
(14755.56%↑ Y/Y)
Back
Back
Balance Sheet
Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN)
source: myfinsight.com